FdaApplication
NDA 008107
Identifiers
- fda_app_no: NDA008107
Properties
| Property | Value |
|---|---|
| applicant_name | HOSPIRA INC |
| application_type | NDA |
| approval_date | 1987-01-30 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LEUCOVORIN CALCIUM | LEUCOVORIN CALCIUM | EQ 60MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SOLUTION;ORAL |
| LEUCOVORIN CALCIUM | LEUCOVORIN CALCIUM | EQ 50MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| LEUCOVORIN CALCIUM | LEUCOVORIN CALCIUM | EQ 350MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| LEUCOVORIN CALCIUM | LEUCOVORIN CALCIUM | EQ 100MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| LEUCOVORIN CALCIUM | LEUCOVORIN CALCIUM | EQ 3MG BASE/ML (EQ 3MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;INTRAMUSCULAR, INTRAVENOUS |
5 products